Swedish Match Seeks FDA Renewal For Modified Risk Marketing Claim; Presents Real-World Evidence Supporting Reduced Harm And Population Health Benefits; Proposes Adjustments To Increase Switching From Smoking And Smokeless Tobacco; Experts Presented To TPSAC On June 26, 2024

7/1/24 4:06:21 PM ET

$MO

$PM

Medicinal Chemicals and Botanical Products

Health Care

Medicinal Chemicals and Botanical Products

Health Care

Get the next $MO alert in real time by email

Swedish Match Seeks FDA Renewal For Modified Risk Marketing Claim; Presents Real-World Evidence Supporting Reduced Harm And Population Health Benefits; Proposes Adjustments To Increase Switching From Smoking And Smokeless Tobacco; Experts Presented To TPSAC On June 26, 2024

Get the next $MO alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MO
$PM

Company	Date	Price Target	Rating	Analyst
Philip Morris International Inc $PM	1/16/2025	$140.00	Overweight	Morgan Stanley
Altria Group Inc. $MO	1/16/2025	$54.00	Equal-Weight	Morgan Stanley
Altria Group Inc. $MO	12/6/2024	$55.00 → $65.00	Neutral → Buy	BofA Securities
Altria Group Inc. $MO	10/8/2024	$44.50 → $48.00	Neutral	Citigroup
Philip Morris International Inc $PM	3/5/2024		Buy → Hold	Argus
Philip Morris International Inc $PM	2/13/2024		Sell → Hold	Societe Generale
Philip Morris International Inc $PM	1/23/2024	$105.00 → $86.50	Buy → Sell	UBS
Altria Group Inc. $MO	1/23/2024		Sell	UBS

More analyst ratings

Philip Morris International to Present at 2025 CAGNY Conference
Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) will host a live audio webcast of a presentation by Jacek Olczak, Chief Executive Officer, and Emmanuel Babeau, Chief Financial Officer, at the Consumer Analyst Group of New York (CAGNY) Conference on Wednesday, February 19, 2025, at 1:00 p.m. ET. The live webcast and presentation slides will be available at www.pmi.com/2025CAGNY. The webcast replay will be available at the same link until Friday, March 21, 2025. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International i
2/12/25 12:07:00 PM ET
$PM
Medicinal Chemicals and Botanical Products
Health Care
Philip Morris International Reports 2024 Fourth-Quarter & Full-Year Results
Delivers 2024 Reported Diluted EPS of $4.52, or $6.01 before Canada non-cash impairment of $1.49, compared to $5.02 in 2023 and Adjusted Diluted EPS of $6.57, Representing Growth of 9.3%, and 15.6% on Currency-Neutral Basis Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2024 fourth-quarter and full-year results.1 "2024 was a remarkable year for PMI. We delivered very strong full-year results driven by the continued growth of IQOS and ZYN in addition to a robust combustibles performance," said Jacek Olczak, Chief Executive Officer. "The long-awaited U.S. FDA authorization of all ZYN nicotine pouches currently marketed in the U.S. is further eviden
2/6/25 6:59:00 AM ET
$PM
Medicinal Chemicals and Botanical Products
Health Care
Altria to Host Webcast From the Consumer Analyst Group of New York Conference
Altria Group, Inc. (Altria) (NYSE:MO) will host a webcast of its business presentation at the annual Consumer Analyst Group of New York conference in Orlando, Florida, on Wednesday, February 19, 2025, at approximately 10:00 a.m. Eastern Time. The webcast will feature a presentation by Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Executive Vice President and Chief Financial Officer. The webcast will be in a listen-only mode. Pre-event registration is necessary; directions are posted at www.altria.com/webcasts. An archived copy of the webcast will be available on altria.com. View source version on businesswire.com: https://www.businesswire.com/news/home/2025
2/5/25 10:00:00 AM ET
$MO
Medicinal Chemicals and Botanical Products
Health Care

Philip Morris International Reports 2024 Fourth-Quarter & Full-Year Results
Delivers 2024 Reported Diluted EPS of $4.52, or $6.01 before Canada non-cash impairment of $1.49, compared to $5.02 in 2023 and Adjusted Diluted EPS of $6.57, Representing Growth of 9.3%, and 15.6% on Currency-Neutral Basis Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2024 fourth-quarter and full-year results.1 "2024 was a remarkable year for PMI. We delivered very strong full-year results driven by the continued growth of IQOS and ZYN in addition to a robust combustibles performance," said Jacek Olczak, Chief Executive Officer. "The long-awaited U.S. FDA authorization of all ZYN nicotine pouches currently marketed in the U.S. is further eviden
2/6/25 6:59:00 AM ET
$PM
Medicinal Chemicals and Botanical Products
Health Care
Altria Reports 2024 Fourth-Quarter and Full-Year Results; Provides 2025 Full-Year Earnings Guidance; Announces New $1 Billion Share Repurchase Program
Altria Group, Inc. (NYSE:MO) today reports our 2024 fourth-quarter and full-year business results and provides our guidance for 2025 full-year adjusted diluted earnings per share (EPS). "2024 was another pivotal year for Altria, headlined by meaningful progress toward our Vision, strong financial results and significant cash returns to shareholders," said Billy Gifford, Altria's Chief Executive Officer. "Our companies' leading brands and talented teams enabled our core tobacco businesses to deliver solid income growth and margin expansion, while we strategically invested in our future." "We expect to deliver 2025 full-year adjusted diluted EPS in a range of $5.22 to $5.37. This range re
1/30/25 7:00:00 AM ET
$MO
Medicinal Chemicals and Botanical Products
Health Care
Philip Morris International Declares Regular Quarterly Dividend of $1.35 Per Share
Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.35 per common share, payable on January 13, 2025, to shareholders of record as of December 26, 2024. The ex-dividend date is December 26, 2024. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio
12/12/24 6:00:00 AM ET
$PM
Medicinal Chemicals and Botanical Products
Health Care

$MO
$PM
Leadership Updates

Live Leadership Updates

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation
Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex
9/17/24 9:11:00 AM ET
$PM
Medicinal Chemicals and Botanical Products
Health Care
Philip Morris International Names New External Affairs Leader
Philip Morris International Inc. (PMI) (NYSE:PM) is pleased to announce the appointment of Christos Harpantidis to the position of Senior Vice President, External Affairs effective May 1, 2024. In his new role, Mr. Harpantidis will report to the company's CEO, Jacek Olczak. "Christos is an experienced business leader with a proven track record of engaging society on the benefits of tobacco harm reduction and risk-proportionate regulation for smoke-free products," said CEO Jacek Olczak. "He has been instrumental in building our smoke-free business in Greece and the South East Europe Area as we evolve away from cigarettes. I'm looking forward to working with Christos and excited to see what
3/26/24 5:48:00 AM ET
$PM
Medicinal Chemicals and Botanical Products
Health Care
Philip Morris International's U.S. Business Champions Female Economic Growth in Connecticut with Record-Setting $5 Million Investment Through New Partnership with Women's Business Development Council
In honor of Women's History Month and in advance of International Women's Day, investment and partnership support female economic empowerment and equality through entrepreneurship Today, Philip Morris International (PMI) (NYSE:PM) announces the launch of an extended partnership via its U.S. business to support female empowerment with a record-setting $5 million investment in the Women's Business Development Council (WBDC), a 501(c)(3) charitable organization dedicated to providing tools and resources to help women entrepreneurs thrive in business throughout Connecticut. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202403048002
3/4/24 6:48:00 PM ET
$PM
Medicinal Chemicals and Botanical Products
Health Care

Swedish Match Seeks FDA Renewal For Modified Risk Marketing Claim; Presents Real-World Evidence Supporting Reduced Harm And Population Health Benefits; Proposes Adjustments To Increase Switching From Smoking And Smokeless Tobacco; Experts Presented To TPSAC On June 26, 2024

Chat with this insight

Recent Analyst Ratings for $MO$PM

$MO$PM Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Vice President and Controller Dobrowolski Reginaldo sold $1,197,630 worth of shares (8,000 units at $149.70), decreasing direct ownership by 19% to 20,799 units (SEC Form 4)

Pr SSEA CIS & MEA Region De Wilde Frederic was granted 30,462 shares and sold $2,168,100 worth of shares (15,000 units at $144.54), increasing direct ownership by 14% to 128,909 units (SEC Form 4)

President, Europe Region Andolina Massimo was granted 22,983 shares, increasing direct ownership by 28% to 105,060 units (SEC Form 4)

$MO$PM SEC Filings

SEC Form 144 filed by Philip Morris International Inc

SEC Form 8-K filed by Altria Group Inc.

SEC Form 10-K filed by Philip Morris International Inc

$MO$PM Press Releases

Fastest customizable press release news feed in the world

$MO$PM Financials

Live finance-specific insights

Philip Morris International to Present at 2025 CAGNY Conference

Philip Morris International Reports 2024 Fourth-Quarter & Full-Year Results

Altria to Host Webcast From the Consumer Analyst Group of New York Conference

Philip Morris International Reports 2024 Fourth-Quarter & Full-Year Results

Altria Reports 2024 Fourth-Quarter and Full-Year Results; Provides 2025 Full-Year Earnings Guidance; Announces New $1 Billion Share Repurchase Program

Philip Morris International Declares Regular Quarterly Dividend of $1.35 Per Share

$MO$PM Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Morgan Stanley initiated coverage on Philip Morris International with a new price target

Morgan Stanley initiated coverage on Altria with a new price target

Altria upgraded by BofA Securities with a new price target

$MO$PM Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Altria Group Inc. (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

$MO$PM Leadership Updates

Live Leadership Updates

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

Philip Morris International Names New External Affairs Leader

Philip Morris International's U.S. Business Champions Female Economic Growth in Connecticut with Record-Setting $5 Million Investment Through New Partnership with Women's Business Development Council

$MO$PM Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Davis Robert Matthews bought $48,599 worth of shares (1,200 units at $40.50), increasing direct ownership by 16% to 8,473 units (SEC Form 4)

Clarke Ian L.T. bought $44,625 worth of shares (1,100 units at $40.57), increasing direct ownership by 18% to 7,145 units (SEC Form 4)

Recent Analyst Ratings for
$MO
$PM

$MO
$PM
Insider Trading

$MO
$PM
SEC Filings

$MO
$PM
Press Releases

$MO
$PM
Financials

$MO
$PM
Analyst Ratings

$MO
$PM
Large Ownership Changes

$MO
$PM
Leadership Updates

$MO
$PM
Insider Purchases